Diligence memo · auto-generated · as of July 2, 2026

HealthReveal, Inc.

HealthReveal, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

HealthReveal, Inc. operates in Healthtech, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

HealthReveal, Inc. has raised $27M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $27M on 2017-02-01.

Most recent recorded round closed around 2017-02-01.

Valuation (modeled)modeled

Provath models HealthReveal, Inc. at approximately $659M (range $63M–$2.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.25× the median modeled value of Series B Healthtech companies in 2016–2018 (33 peers) — value vs value, same stage and era. Within the normal band (125% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 9.4 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 84% of Healthtech peers (2138 compared).

Modeled value ranks above 95% of those peers.

Closest niche peers: Altimate Medical Holdings, Inc., Southeast Healthcare Partners II, LLC, NRS Health & Wellness GP LLC, Aspire Health, Inc., Uprising Health LLC.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.